Search Results - "Hella, B"

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial by Mosenzon, Ofri, Blicher, Thalia Marie, Rosenlund, Signe, Eriksson, Jan W, Hels, Ole Holm, Pratley, Richard, Sathyapalan, Thozhukat, Desouza, Cyrus, Abramof, R, Aronoff, S, Barker, B, Benson, M, Biggs, W, Blaze, K, Bogdanski, P, Busch, R, Chandran, S, Chang, A, Chilka, S, Cleland, A, Connery, L, Delgado, B, Desouza, C, Donner, T, Eliasson, K, Eriksson, J, Folkerth, S, Forshaw, K, Frolova, E, Gandy, W, Gatipon, G, Golovach, A, Gonzalez-Orozco, L, Gumprecht, J, Hansen, T K, Hasan, S, Hella, B, Heller, S, Hellgren, M, Hewitt, M, Hietaniemi, S, Hitz, M, Houser, P, Huntley, R, Jackson, R, Jakobsen, P E, Kapoor, A, Kargina, L, Kazakova, E, Khan, K, Klein, E, Knoble, H, Krasnopeeva (Kabachkova), N, Kunitsyna, M, Lawhead, J, Levin, P, Lewy-Alterbaum, L, Lindmark, S, Lindsay, R, Luts, A, Lysenko, T, Madsbad, S, Maxwell, T, Mcknight, J, Metsärinne, K, Milovanova, T, Mosenzon, O, Nabriski, D, Nicol, P, Nieminen, S, Nikkola, A, Norwood, P, O'Donnell, P, Odugbesan, A, Parker, J, Pergaeva, Y, Peskov, A, Plevin, S, Pouzar, J, Pratley, R, Reed, J, Rossing, P, Sathyapalan, T, Sergeeva-Kondrachenko, M, Shaikh, Z, Shamkhalova, M, Shehadeh, N, Shlesinger, Y, Silver, R, Snyder, B, Soufer, J, Strand, J, Sulosaari, S, Tirosh, A, Traylor, H, Uhlenius, N, Vagapova, G, Yanovskaya, M, Zarutskaya, L, Zhdanova, E

“…Oral semaglutide is the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for glycaemic control in patients with type 2 diabetes. Type 2 diabetes is…”
Get full text

An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort by Olloni, Agon, Lorenzen, Ebbe Laugaard, Jeppesen, Stefan Starup, Diederichsen, Axel, Finnegan, Robert, Hoffmann, Lone, Kristiansen, Charlotte, Knap, Marianne, Milo, Marie Louise Holm, Møller, Ditte Sloth, Pøhl, Mette, Persson, Gitte, Sand, Hella M.B., Sarup, Nis, Thing, Rune Slot, Brink, Carsten, Schytte, Tine

“…•An automatic hybrid segmentation method for delineation of the heart and substructures.•nnU-net and multi-atlas based method.•Developed on locally advanced…”
Get full text

Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy by Hansen, Christian Rønn, Johansen, Jørgen, Samsøe, Eva, Andersen, Elo, Petersen, Jørgen B.B., Jensen, Kenneth, Andersen, Lisbeth J., Sand, Hella M.B., Bertelsen, Anders S., Grau, Cai

“…Defining margins around the Gross Tumour Volume (GTV) to create a Clinical Target Volume (CTV) for head and neck cancer radiotherapy has traditionally been…”
Get full text

Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers by Sand, Hella M B, Brunø, Anne H, Andersen, Lisbeth J, Carl, Jesper

Get more information

3017: SABR of bony oligometastases, 1-year, efficacy, and toxicity analyses from the Bony-M trial by Spindler, Nicklas J., Felter, Mette v O, Hansen, Olfred, Nielsen, Tine B., Suppli, Morten H., Josipovic, Mirjana, Poulsen, Laurids Ø, Gaard-Petersen, Fatma, Andersen, Michael B., Sand, Hella M B, Johansen, Marie, Madsen, Kasper, Kornerup, Josefine S., Alsaker, Mirjam D., Serup-Hansen, Eva, Eefsen, Rikke L., Vogelius, Ivan R., Geertsen, Poul, Behrens, Claus P., Persson, Gitte F.

Get full text

The community atmospheric chemistry box model CAABA/MECCA-4.0 by Sander, Rolf, Baumgaertner, Andreas, Cabrera-Perez, David, Frank, Franziska, Gromov, Sergey, Grooss, Jens-Uwe, Harder, Hartwig, Huijnen, Vincent, Jockel, Patrick, Karydis, Vlassis A, Niemeyer, Kyle E, Pozzer, Andrea, Riede, Hella, Schultz, Martin G, Taraborrelli, Domenico, Tauer, Sebastian

“…We present version 4.0 of the atmospheric chemistry box model CAABA/MECCA that now includes a number of new features: (i) skeletal mechanism reduction, (ii)…”
Get full text

Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapy by Olloni, Agon, Brink, Carsten, Lorenzen, Ebbe L., Jeppesen, Stefan S., Hoffmann, Lone, Kristiansen, Charlotte, Knap, Marianne M., Møller, Ditte S., Nygård, Lotte, Persson, Gitte F., Thing, Rune S., Sand, Hella MB, Diederichsen, Axel, Schytte, Tine

“…Coronary artery calcium score (CACs) is an excellent marker for survival in non-cancer patients, but its role in locally advanced non-small cell lung cancer…”
Get full text